1589. Akilandeswari G, Deka G, Prabhavathi M, Savithri HS, Murthy MRN, Raja A. Structural and biophysical characterization of Rv3761c, a hypothetical protein from Mycobacterium tuberculosis. Biochemical and Biophysical Research Communications, 2018;495(1):982-987.

1590. Rao VG, Muniyandi M, Bhat J, Yadav R, Sharma R. Research on tuberculosis in tribal areas in India: A systematic review. Indian Journal of Tuberculosis, 2018;65(1):8-14.

1591. Arunmozhivarman K, Radhika R, Kannan P, Maroudam V, Vijayalakshmi K, Claudet PV, Raj G. Isolation and identification of M. tuberculosis from sheep tissue samples and sero-diagnosis study in an organized sheep farm. International Journal of Current Microbiology and Applied Sciences, 2018;7(1):2740-2744.

1592. Kumar NP, Banurekha VV, Nair D, Dolla C, Kumaran P, Babu S. Modulation of iron status biomarkers in tuberculosis-diabetes co-morbidity. Tuberculosis (Edinb).2018; 108:127-135.

1593. Srinivasan, R. Ponnuraja. C Venkatesan, P. Bayesian multivariate conditional autoregressive model for tuberculosis and HIV in India. Indian Journal of Applied Research, 2018;8(1): 148-150.

1594. Manson AL, Abeel T, Galagan JE, Sundaramurthi JC, Siva Kumar S, Kannan P, Narayanan S, Swaminathan S, Earl AM; Reply to Lee and Howden. Clinical Infectious Diseases, 2018;66(1):160–161.

1595. Khusro A, Aarti C, Dusthackeer A, Agastian P. Anti-tubercular and probiotic properties of coagulase-negative staphylococci isolated from Koozh, a traditional fermented food of south India. Microbial Pathogenesis, 2018;114::239-250.

1596. Raizada N, Khaparde SD, Salhotra VS, Rao R, Kalra A, Swaminathan S, Khanna A, Chopra AK, Hanif M, Singh V, Uma Devi KR, Nair SA, Huddart S, Surya Prakash CH, Mall S, Singh P, Saha BK, Denkinger CM, Boehme C, Sarin S. Accelerating access to quality TB care for pediatric TB cases through better diagnostic strategy in four major cities of India. PLoS One, 2018;13(2):e0193194.

1597. Anuradha R, Munisankar S, Bhootra Y, Dolla CK, Nutman TB, Babu S. Elevated systemic levels of eosinophil, neutrophil, and mast cell granular proteins in Strongyloides Stercoralis infection that diminish following treatment. Frontiers in Immunology, 2018;9:207.

1598. Harishankar M, Ravikrishnan H, Ravishankar A, Elizabeth LH, Swaminathan S, Selvaraj P, Ramalingam B. IL-10 promoter -592 polymorphism may influence susceptibility to HIV infection in South Indian population. Current HIV Research, 2018; 16(1):58-63.

1599. Poongkodi K, Chandrasekaran M, Srinivasan R, Suresh VR. Is hungry bone syndrome a cause of postoperative hypocalcemia after total thyroidectomy in thyrotoxicosis? A prospective study with bone mineral density correlation. Surgery, 2018;163(1):367-372.

1600. Praphakar RA, Shakila H, Azger Dusthackeer VN, Munusamy MA, Suresh Kumar, Rajan M. A mannose conjugated multi-layered polymeric nano carrier system for controlled and targeted release on alveolar macrophages. Polymer Chemistry, 2018; 9(5):656-667.

1601. Veesa KS, John KR, Moonan PK, Kaliappan SP, Manjunath K, Sagili KD, Ravichandra C, Menon PA, Dolla C, Luke N, Munshi K, George K, Minz S. Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment - Tamil Nadu, India. PLoS One, 2018;13(2):e0191591.

1602. Nair D, Banurekha V, Marimuthu M, Poornagangadevi N, Ponnuraja C, Jawahar MS, Swaminathan S. Effect of moxifloxacin on QTc interval in adults with pulmonary tuberculosis. National Medical Journal of India, 2018;31(1):58- 59.

1603. Akilandeswari G, Raghu B, Nagasuma C, Savithri H, Raja A, Ramalingam B. Biophysical and biochemical characterization of Rv3405c, a tetracycline repressor protein from Mycobacterium tuberculosis. Biochemical and Biophysical Research Communications, 2018; 496(3):799-805.

1604. Balaji P, Santhi D, Raja A. Altered expression of antigen-specific memory and regulatory T cell subsets differentiate latent and active tuberculosis. Immunology, 2018;153(3):325-336.

1605. Padmapriyadarsini C, Shet A, Srinivasan R, Ramachandran G, Sanjeeva GN, Devi P, Ramesh K, Bhavani PK, Reddy D, Suresh E, Chandrasekhar C, Wanke C, Swaminathan S. High prevalence of lipid abnormalities and insulin resistance among antiretroviral naïve HIV-infected children in India. Pediatric Infectious Disease Journal, 2018;37(3): 253-257.

1606. Balaji P, Santhi D, Prabhavathi M, Raja A. Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB - a flow cytometry-based analysis. International Journal of Medical Microbiology, 2018;308(2):297-305.

1607. Raizada N, Khaparde SD, Swaminathan S, Sarin S, Salhotra VS, Kalra A, Khanna A, Chopra KK, Hanif M, Umadevi KR, Hissar S, Nair SA, Surya Prakash CH, Saha BK, Rao R, Denkinger C, Boehme C. Catalysing progressive uptake of newer diagnostics by health care providers through outreach and education in four major cities of India. PLoS One, 2018;13(3):e0193341.

1608. Kumarasingam K, Vincent M, Shivshankar R. Mane SR, Shunmugam R, Sivakumar S, Uma Devi KR. Enhancing Antimycobacterial Activity of Isoniazid and Rifampicin Incorporated Norbornene Nanoparticles. International Journal of Mycobacteriology, 2018;7(1):84-88.

1609. Thomas BE, Subbaraman R, Sellappan S, Suresh C, Lavanya J, Lincy S, Raja AL, Javeed B, Kokila S, Arumugam S, Swaminathan S, Mayer KH. Pretreatment loss to follow-up of tuberculosis patients in Chennai, India: a cohort study with implications for health systems strengthening. BMC Infectious Disease, 2018;18(1):142

1610. Rajeswari R, Muniyandi M. Rapid molecular diagnosticis for drug-resistant tuberculosis in India. Expert Review of Anti-infective Therapy, 2018;16(3):197-204.

1611. Catherine Rexy D, Mokesh Rayalu G, Ponnuraja C. Unshared gamma frailty model in tuberculosis patient. International Journal of Research in Pharmaceutical Sciences, 2018;9(1):103-108.

1612. Hemanth Kumar AK, Chandrasekaran V, Kannan T, Lavanya J, Swaminathan S, Ramachandran G. Intrapatient variability in plasma rifampicin & isoniazid in tuberculosis patients. Indian J Med Res.2018;147(3):287-292.

1613. Narayanaiah C, Hemalatha B, Anangi B, Muthuramalingam K, Selvachithiram M, Sathyamurthi P, Kailasam N, Varadarajan R, Swaminathan S, Tripathy SP, Vaniambadi SK, Vadakkupattu DR, Hanna LE. Evolution of neutralization response in HIV-1 subtype C-infected individuals exhibiting broad cross-clade neutralization of HIV-1 strains. Frontiers in Immunology, 2018;9:618:1-16.

1614. Madhumitha H, Mohan V, Babu S, Aravindhan V. TLR-induced secretion of novel cytokine IL-27 is defective in newly diagnosed type-2 diabetic subjects. Cytokine, 2018;104:65-71.

1615. Arunkumar V, Knannan P, Sharma D, Bhist D, Narayanan S. Characterization of FtsY, its interaction with Ffh and proteomic identification of their potential substrates in Mycobacterium tuberculosis. Canadian Journal of Microbiology, 2018;64(4):243-251.

1616. Hemanth Kumar AK, Polisetty AK, Sudha V, Vijayakumar A, Ramachandran G. A selective and sensitive high performance liquid chromatography assay for the determination of cycloserine in human plasma. Indian Journal of Tuberculosis, 2018;65(2):118-123.

1617. Gopalan N, Santhanakrishnan RK, Palaniappan AN, Menon PA, Lakshman S, Padmapriyadarsini C, Gomathi NS, Reddy D, Kannabiran BP, Hemanth Kumar AK, Krishnamoorthy V, Rathinam S, Chockalingam C, Manoharan T, Ayyamperumal M, Jayanthi N, Satagopan K, Narayanan R, Krishnaraja R, Sathiyavelu S, Kesavamurthy B, Suresh C, Selvachitiram M, Arasan G, Susaimuthu S, Rathinam P, Angamuthu P, Jayabal L, Murali L, Ramachandran R, Tripathy SP, Swaminathan S. Daily vs Intermittent antituberculosis therapy for pulmonary tuberculosis in patients with HIV. A Randomized clinical trial. JAMA Internal Medicine, 2018;178(4):485-493.

1618. Fregonese F, Ahuja SD, Akkerman OW, Arakaki-Sanchez D, Ayakaka I, Baghaei P, Bang D, Bastos M, Benedetti A, Bonnet M, Cattamanchi A, Cegielski P, Chien JY, Cox H, Dedicoat M, Erkens C, Escalante P, Falzon D, Garcia-Prats AJ, Gegia M, Gillespie SH, Glynn JR, Goldberg S, Griffith D, Jacobson KR, Johnston JC, Jones-López EC, Khan A, Koh WJ, Kritski A, Lan ZY, Lee JH, Li PZ, Maciel EL, Galliez RM, Merle CSC, Munang M, Narendran G, Nguyen VN, Nunn A, Ohkado A, Park JS, Phillips PPJ, Ponnuraja C, Reves R, Romanowski K, Seung K, Schaaf HS, Skrahina A, Soolingen DV, Tabarsi P, Trajman A, Trieu L, Banurekha VV, Viiklepp P, Wang JY, Yoshiyama T, Menzies D. Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis. Lancet Respiratory Medicine, 2018;6(4):265-275.

1619. Padmapriyadarsini C, Das M, Nagaraja SB, Mahalakshmi R, Kirubakaran R, Chadha S, Tharyan P. Is Chemoprophylaxis for Child Contacts of Drug-Resistant TB Patients Beneficial? A Systematic Review. Tuberculosis Research and Treatment, 2018;Article ID 3905890:1-8.

1620. Ashokkumar M, Aralaguppe SG, Tripathy SP, Hanna LE, Neogi U. Unique phenotypic characteristics of recently transmitted HIV-1 subtype C envelope glycoprotein gp120: Use of CXCR6 co-receptor by transmitted founder viruses. Journal of Virology, 2018;92(9).

1621. Gokul Raj K, Moideen K, Baskaran D, Sekar G, Rathinam S, Bharathi VJ, Ganeshan GR, Babu S. Tuberculous lymphadenitis is associated with altered levels of circulating angiogenic factors. International Journal of Tuberculosis and Lung Disease, 2018; 22(5):557–566.

1622. Hemanth Kumar AK, Kumar A, Kannan T, Bhatia R, Agarwal D, Kumar S, Dayal R, Singh SP, Ramachandran G. Pharmacokinetics of second-line anti-tuberculosis drugs in children with multidrug-resistant tuberculosis in India. Antimicrobial Agents and Chemotherapy, 2018;62(5):1-9.

1623. Muthu M, Anbarasu D, Ramachandran D, Paul D, Gopal J, Chun S. A state-of-art review on the agility of quantitative proteomics in tuberculosis research. Trends in Analytical Chemistry, 2018;102:369-378.

1624. Anuradha R, Munisankar S, Bhootra Y, Dolla CK, Kannan T, Nutman TB, Babu S. Altered levels of memory T cell subsets and common γc cytokines in Strongyloides stercoralis infection and partial reversal following anthelmintic treatment. PLoS Neglected Tropical Diseases, 2018;12(5):e0006481.

1625. Ramakrishnan K, Shenbagarathai R, Binuramesh C, Kavitha K, Uma A, Thirumalaikolundusubramanian P, Rathinasabapati R. Bacterial isolates of lower respiratory tract infection among subjects with and without HIV from south India. International Journal of Biological and Medical Research, 2018;9(3):6438-6440.

1626. Shivakumar SVBY, Padmapriyadarsini C, Kumar AMV, Paradkar M, Dhanasekaran K, Suryavarshini N, Thomas B, Kohli R, Thiruvengadam K, Kulkarni V, Hannah LE, Gomathi NS, Pradhan N, Dolla C, Gupte A, Ramachandran G, DeLuca A, Meshram S, Bhardawaj R, Bollinger RC, Golub J, Selvaraj K, Gupte N, Swaminathan S, Mave V, Gupta A; for the CTRIUMPh-RePORT India Study Team. Diabetes and pre-diabetes among household contacts of tuberculosis patients in India: is it time to screen them all? International Journal of Tuberculosis and Lung Disease, 2018;22(6):686–694.

1627. Kadar M, Kumar NP, Nair D, Banurekha VV, Ramalingam B, Babu S. Heightened systemic levels of neutrophil and eosinophil granular proteins in pulmonary tuberculosis and reversal following treatment. Infection and Immunity, 2018;86(6).

1628. GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet, 2018;391(10136):2236-2271.

1629. Rao VG, Bhat J, Yadav R, Sharma R, Muniyandi M. A comparative study of the socio-economic risk factors for pulmonary tuberculosis in Saharia tribe of Madhya Pradesh, India. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2018:112(6):272-278.

1630. Rajasekaran S, Anuradha S, Ramalingam B, Manokaran G. Successful multi-modality treatment of Grade IV lymphedema in lymphatic filariasis: A case study. Lymphology, 2018;51(2):89-92.

1631. Banurekha VV, Chadha VK, Singla N, Narang P, Gangadhar Rao V, Nair S, Ramalingam S, Gomathi NS, Joseph B, Selvaraju S, Sivakumar S, Narang R, Pachikkaran P, Bhat J, Ponnuraja C, Bajaj Bhalla B, Shivashankara BA, Sebastian G, Yadav R, Kumar Sharma R, Sarin R, Myneedu VP, Singla R, Khayyam K, Mrithunjayan SK, Jayasankar SP, Sanker P, Viswanathan K, Viswambharan R, Mathuria K, Bhalla M, Singh N, Tumane KB, Dawale A, Tiwari CP, Bansod R, Jayabal L, Murali L, Khaparde SD, Rao R, Jawahar MS, Natrajan M. Recurrence of tuberculosis among newly diagnosed sputum positive pulmonary tuberculosis patients treated under the Revised National Tuberculosis Control Programme, India: A multi-centric prospective study. PLoS One, 2018;13(7):e0200150.

1632. Arunkumar V, Knannan P, Narayanan S. Molecular characterization of AmiC, a positive regulator in acetamidase operon of Mycobacterium smegmatis. Cell Stress and Chaperones, 2018;23(4):539-550.

1633. Mimiaga MJ, Thomas B, Mayer KH, Regenauer KS, Dange A, Andres Bedoya C, Rawat S, Balu V, O'Cleirigh C, Biello KB, Anand V, Swaminathan S, Safren SA. A randomized clinical efficacy trial of a psychosocial intervention to strengthen self-acceptance and reduce HIV risk for MSM in India: study protocol. BMC Public Health.2018;18(1):890.

1634. Khusro A, Aarti C, Azger D, Agastian P. Enhancement of anti-tubercular activity and biomass of fermented food associated Staphylococcus hominis strain MANF2 using Taguchi orthogonal array and Box-Behnken design. Microbial Pathogenesis.2018;120:8-18.

1635. Kumar NP, Moideen K, Viswanathan V, Shruthi BS, Sivakumar S, Menon PA, Kornfeld H, Babu S. Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment. BMC Infectious Disease, 2018;18(1):345.

1636. Pavithra S, Kadar M, Uma Devi R, Ramalingam B. Monocyte subsets: Phenotypes and Function in tuberculosis infection. Frontiers in Immunology. 2018;9:1726-1-8.

1637. Unissa AN, Doss C GP, Kumar T, Sukumar S, Lakshmi AR, Hanna LE. Significance of catalase-peroxidase (KatG) mutations in mediating isoniazid resistance in clinical strains of Mycobacterium tuberculosis. Journal of Global Antimicrobial Resistance, 2018;15:111-120.

1638. Zayed H, Abdel Motal UM, Gopalakrishnan A, Ponnuraja C, Doss CGP, Rizk N, Shebl FM. Retinopathy of Type 1 Diabetes in Arab Countries: Systematic Review and Meta-Analysis. Ophthalmic Research, 2018;1-12.

1639. Kumar NP, Moideen K, Banurekha VV, Nair D, Babu S. Modulation of Th1/Tc1 and Th17/Tc17 responses in pulmonary tuberculosis by IL-20 subfamily of cytokines. Cytokine, 2018;108:190-196.

1640. Padmapriyadarsini C, Mave V, Kannan T, Gupte N, Shivakumar SVBY, Hanna LE, Kulkarni V, Kadam D, Dhanasekaran K, Paradkar M, Thomas B, Kohli R, Dolla CK, Bharadwaj R, Gomathi NS, Pradhan N, Gupte A, Murali L, Valvi C, Swaminathan S, Gupta A; CTRIUMPH Study Team. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting. PLoS One, 2018;13(8):e0199360.

1641. Harishankar M, Selvaraj P, Ramalingam B. Influence of Genetic polymorphism towards pulmonary tuberculosis susceptibility. Frontiers in Medicine,2018;5:1-18.

1642. Ponnan SM, Swaminathan S, Kannan T, K K V, Narayanaiah C, Nesakumar M, Kathirvel S, Goyal R, Singla N, Mukherjee J, Bergin P, T Kopycinski J, Gilmour J, Tripathy SP, Hanna LE. Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India. PLoS One, 2018 ;13(8):e0203037.

1643. Raizada N, Khaparde SD, Rao R, Kalra A, Sarin S, Salhotra VS, Swaminathan S, Khanna A, Chopra KK, Hanif M, Singh V, Umadevi KR, Nair SA, Huddart S, Tripathi R, Surya Prakash CH, Saha BK, Denkinger CM, Boehme C. Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation. PLoS One, 2018;13(8):e0202085.

1644. Ramachandran R, Muniyandi M. Towards improved treatment outcomes for tuberculosis meningitis - Rethinking the regimen. Journal of Neurology & Neurosurgery, 2018;8(2):1-6.

1645. Pattarayan D, Sivanantham A, Ramalingam B, Palanichamy R, Rajasekaran S. Tannic acid modulates fibroblast proliferation and differentiation in response to pro-fibrotic stimuli. J Cell Biochem.2018;119(8):6732-6742.

1646. Afsal K, Selvaraj P, Harishankar M. 1, 25-dihydroxyvitamin D3 downregulates cytotoxic effector response in pulmonary tuberculosis. International Immunopharmacology. 2018;62:251-260.

1647. Shivakoti R, Gupte N, Kumar NP, Kulkarni V, Balasubramanian U, Bhosale R, Sambrey P, Kinikar A, Bharadwaj R, Patil S, Inamdar S, Suryavanshi N, Babu S, Bollinger RC, Gupta A. Intestinal barrier dysfunction and microbial translocation in human immunodeficiency virus–infected pregnant women are associated with preterm birth. Clinical Infectious Diseases, 2018;67(7):1103-1109.

1648. Hassan S, Srikakulam SK, Yuvaraj C, Thangam M, Muthukumar S, Gayathri Devi PK, Hanna LE. Exploring the conformational landscapes of HIV protease structural ensembles using principal component analysis. Proteins, 2018;86(9):990-1000.

1649. Radhakrishnan R, Prabuseenivasan S, Balaji S, Sangamithirai D, Nagarajan P, Ponnuraja C, Uma Devi KR, Kumar V, Selvakumar N. Assessment of Training on Culture and Drug Sensitivity Testing of Mycobacterium tuberculosis at a National Reference Laboratory. Mycobacterial Diseases.2018;2018;8(3):1-4.

1650. Guiastrennec B, Ramachandran G, Karlsson MO, Kumar AKH, Bhavani PK, Gangadevi NP, Swaminathan S, Gupta A, Dooley KE, Savic RM. Suboptimal anti-tuberculosis drug concentrations and outcomes in small and HIV coinfected children in India: Recommendations for dose modifications. Clinical Pharmacology & Therapeutics, 2018;104(4):733-741.

1651. Kadar M, Kumar NP, Nair D, Banurekha VV, Babu S. Altered systemic Adipokine levels in pulmonary tuberculosis and changes following treatment. The American Journal of Tropical Medicine and Hygiene, 2018;99(4):875-880.

1652. Abdel-Motal UM, G A, Abdelalim EM, Ponnuraja C, Iken K, Jahromi M, Doss GP, El Bekay R, Zayed H. Prevalence of nephropathy in type 1 diabetes in the Arab world: A systematic review and meta-analysis. Diabetes Metabolism Research and Reviews, 2018;34(7):e3026.

1653. Alfarisi O, Mave V, Gaikwad S, Sahasradubhe T, Ramachandran G, Kumar H, Gupte N, Kulkarni V, Deshmukh S, Atre S, Raskar S, Lokhande R, Barthwal M, Kakrani A, Gupta A, Golub JE, Dooley KE. Effect of diabetes mellitus on the pharmacokinetics and pharmacodynamics of tuberculosis treatment. Antimicrobial Agents and Chemotherapy, 2018;62(11).

1654. Subbaraman R, de Mondesert L, Musiimenta A, Pai M, Mayer KH, Thomas BE, Haberer J. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities. BMJ Global Health, 2018; 3(5):e001018.

1655. Moonan PK, Nair SA, Agarwal R, Chadha VK, Dewan PK, Gupta UD, Ho CS, Holtz TH, Kumar AM, Kumar N, Kumar P, Maloney SA, Mase SR, Oeltmann JE, Paramasivan CN, Parmar MM, Rade KK, Ramachandran R, Rao R, Salhorta VS, Sarin R, Sarin S, Sachdeva KS, Selvaraju S, Singla R, Surie D, Tonsing J, Tripathy SP, Khaparde SD. Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India. BMJ Global Health, 2018;3(5):e001135.

1656. Anuradha R, Saravanan M, Yukthi B, Dolla CK, Nutman TB, Babu S. Elevated systemic and parasite-antigen stimulated levels of type III IFNs in a chronic helminth infection and reversal following anthelmintic treatment. Frontiers in Immunology, 2018;9:Article 2353.

1657. Sagili KD, Muniyandi M, Nilgiriwala KS, Shringarpure KS, Satyanarayana S, Kirubakaran R, Chadha SS, Tharyan P. Cost-effectiveness of GeneXpert and LED-FM for diagnosis of pulmonary tuberculosis: A systematic review. PLoS One, 2018;13(10):e0205233.

1658. Anuradha R, Munisankar S, Bhootra Y, Kumar NP, Dolla C, Babu S. Malnutrition is associated with diminished baseline and mycobacterial antigen - stimulated chemokine responses in latent tuberculosis infection. Journal of Infection, 2018; 77(5):410-416.

1659. Gokul Raj K. Moideen K, Banurekha VV, Nair D, Sridhar R, Baskaran D, Babu S. Altered circulating levels of B cell growth factors and their modulation upon anti-tuberculosis treatment in pulmonary tuberculosis and tuberculous lymphadenitis. PLoS One, 2018;13(11):e0207404.

1660. Padmapriyadarsini C, Shet A, Srinivasan R, Sanjeeva GN, Subramanyan S, Sunderesan S, Ramesh K, Gopalan B, Suresh E, Poornagangadevi N, Hanna LE, Chandrasekar C, Wanke C, Swaminathan S. Long-term virological outcome in children receiving first-line antiretroviral therapy. AIDS Research and Therapy, 2018;15(1):23.

1661. GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018;392(10159):1684-1735.

1662. GBD 2017 Population and Fertility Collaborators. Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018;392(10159):1995-2051.

1663. GBD 2017 SDG Collaborators. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018;392(10159):2091-2138.

1664. Gokul Raj K, Kumar NP, Kadar M, Baskaran D, Hissar S, Shrinivasa BM, Sridhar R, Babu S. Diminished circulating plasma and elevated lymph node culture supernatant levels of IL-10 family cytokines in tuberculous lymphadenitis. Cytokine, 2018; 111:511-517.

1665. Dayal R, Singh Y, Agarwal D, Kumar M, Swaminathan S, Ramachandran G, Kumar S, Narayan S, Goyal A, Kumar AKH. Pharmacokinetic study of isoniazid and pyrazinamide in children: impact of age and nutritional status. Archives of Disease in Childhood, 2018;103(12):1150-1154.

1666. Noordin R, Yunus MH, Robinson K, Won KY, Babu S, Fischer PU, Hisam S, Mahmud R. Laboratory Evaluation of a Rapid IgG4 Antibody Test (BLF Rapid™) for Bancroftian Filariasis. American Journal of Tropical Medicine and Hygiene, 2018;99(6):1587-1590.

1667. Vidyavijayan KK, Narayanaiah C, Hemalatha B, Precilla LK, Sathyamurthi P, Chandrasekaran P, Murugavel KG, Swaminathan S, Tripathy SP, Hanna LE. Cross Type Neutralizing Antibodies Detected in a Unique HIV-2 Infected Individual From India. Frontiers in Immunology, 2018,9:2841.

1668. Mukherjee F, Bahekar VS, Pasha SY, Kannan P, Prasad A, Rana SK, Kanani A, Sharma GK, Premalatha D, Srinivasan VA. Isolation and analysis of the molecular pidemiology and zoonotic significance of \ Mycobacterium tuberculosis in domestic and wildlife ruminants from three states in India. Revue Scientific et Technique, 2018,37(3):999-1012.

1669. Jayalalitha S, Vidyarani S, Aravindha Babu N, Subbaih S, Mani JG, Ponnuraja C, , Rajeswary H. Evaluation of serum toll-like receptor 4 and nuclear factor-?bp65 proteins in oral squamous cell carcinoma . Asian Journal of Pharmaceutical and Clinical Research, 2018; 11(12):179-182.

1670. Suzana S, Sivakumar S, Swarna Latha PN, Michael JS. Molecular genotyping to differentiate endogenous reactivation and exogenous reinfection of recurrent tuberculosis . Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2018; 13:17-21.

1671. Mohanta BC, Dinda SC, Mishra G, Palei NN, Nynar V, Azger D. Formulation, characterization, in vitro anti-tubercular activity and cytotoxicity study of solid lipid nanoparticles of Isoniazid. Nano Biomedicine and Engineering, 2018;10(4):379-391.

1672. Tiwari S, Barh D, Imchen M, Rao E, Kumavath RK, Seenivasan SP, Jaiswal AK, Jamal SB, Kumar V, Ghosh P, Azevedo V. Acetate kinase (AcK) is essential for microbial growth, and betel compounds potentially target AcK, PhoP and MDR proteins in M. tuberculosis , V. cholerae and pathogenic E. coli : An in silico and in vitro study. Current Topics in Medicinal Chemistry, 2018; 18(31):2731-2740.

1673. Sasikumar K, Ghosh AR, Azger D. Antimycobacterial potentials of quercetin and rutin against Mycobacterium tuberculosis H37Rv. 3 Biotech, 2018;8(10):Article 427;1-7.

1674. Prabhakaran R, Pooranagangadevi N, Mahalakshmi R, Bharathi Babu K, Elamparithi S. Fiberoptic bronchoscopy for the rapid diagnosis of suspected pulmonary tuberculosis. Journal of Infectious Diseases & Research, 2018;1(1):5-8.

1675. Muthuvijayalakshmi M, Kumar E, Ponnuraja C. Comparison of artificial neural network and rough set for disease classification. Journal of Applied Science and Computations, 2018;11(5):68-73.

1676. Meeran SI, Tajudeen SS, Azger Dusthakeer VN, Shabeer TK. An insight into the anti-tubercular potential of schiff bases. Journal of Pharmaceutical, Chemical and Biological Sciences, 2018;6(3):158-177.

1677. Muthuvijayalakshmi M, Kumar E, Ponnuraja C. Neural network based tuberculosis disease classification. International Journal of Scientific Research and Reviews, 2018; 7(3):514-522.

1678. Sivasankaran. MP , Swaminathan S, Kannan T, Vidya Vijayan KK, Narayanaiah C , Nesakumar M, Kathirvel S, Goyal R, Singla N, Mukherjee J, Bergin P, Kopycinski JT, Gilmour J, Tripathy SP, Hanna LE. Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India. PLoS One, 2018; 13(8):e0203037.

1679. Manikandan P, Rajasekar K, Azger Dusthakeer VN, Mahizhaveni B., Veeravel C. Synthesis, characterization, DNA binding, DNA cleavage and antimycobacterial studies of Cu(II) complex with Isoniazid and oxalate ion. Journal of Chemistry and Chemical Sciences, 2018; 8(5):810-817.

1680. Palumbo PJ, Fogel JM, Hudelson SE, Wilson EA, Hart S, Hovind L, Piwowar-Manning E, Wallis C, Papathanasopoulos MA, Morgado MG, Saravanan S, Tripathy S, Eron JJ, Gallant JE, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Pilotto JH, Kumwenda J, Akelo V, Godbole SV, Santos BR, Grinsztejn B, Pa nchia R, Chariyalertsak S, Makhema J, Badal-Faesen S, Chen YQ, Cohen MS, Eshleman SH. HIV drug resistance in adults receiving early vs. delayed antiretroviral therapy: HPTN 052. Journal of Acquired Immune Deficiency Syndrome, 2018 Apr 15;77(5):484-491.

1681. Jayalalitha S, Vidyarani S, Aravindha Babu N, Shanmugam S, Mani JG, Ponnuraja C, Aparna K, Rajeswary H. Study on PIK3CA gene mutations in oral squamous cell carcinoma among south Indian populations. Biomedical and Pharmacology Journal, 2018; 11(2):1023-1030.

1682. Chabala C, Turkova A, Thomason MJ, Wobudeya E, Hissar S , Mave V, van der Zalm M, Palmer M, Kapasa M, Bhavani PK, Balaji S, Raichur PA, Demers AM, Hoddinott G, Owen-Powell E, Kinikar A, Musoke P, Mulenga V, Aarnoutse R, McIlleron H, Hesseling A , Crook AM, Cotton M, Gibb DM ; and on behalf of the SHINE trial team . Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomized controlled trial. Trials, 2018;19(1):237-1-12.